Market News

HKTDCen





Market News
Items Per Page
Title Source Publish Date
1.
New Import Controls on Ten Synthetic Cathinones
The Drug Enforcement Administration has issued a final rule that, effective 1 March, placed the following synthetic cathinones, including their optical, positional and geometric isomers, salts and salts of isomers whenever their existence is possible, into schedule I of the Controlled Substances Act.
Economists' Pick 17 March 2017
2.
Vast Indonesian Food and Pharma Sectors Lure Overseas Manufacturers
The sheer size and the rapid projected growth rate of Indonesia's pharmaceutical and food and beverage manufacturing sectors have proven to be irresistible lures to many of the world’s leading processing and industrial machinery suppliers.
Economists' Pick 3 March 2017
3.
Import Restrictions on Three Synthetic Cannabinoids Extended
The Drug Enforcement Administration has extended the temporary placement of three synthetic cannabinoids into Schedule I of the Controlled Substances Act until 27 January 2018 or until a permanent scheduling proceeding is completed, whichever occurs first.
Economists' Pick 17 Feb 2017
4.
INDONESIA: Mandatory Halal Certification Looms for Food, Pharmaceuticals and Cosmetics
Halal certification will be mandatory for all food, pharmaceutical and cosmetic products from October 2019. Promoted as a Halal Product Guarantee, the certification forms part of the bid to make Indonesian products more competitive in the international market, especially among the world’s estimated 1.9 billion global Muslim consumers.
Economists' Pick 25 Jan 2017
5.
FDA Bans Powdered Medical Gloves
The Food and Drug Administration has issued a final rule that, effective 18 January, will ban powdered surgeon’s gloves, powdered patient examination gloves, and absorbable powder for lubricating a surgeon’s glove after having determined that these goods present an unreasonable and substantial risk of illness or injury that cannot be corrected or eliminated by labelling or a change in labelling.
Economists' Pick 6 Jan 2017
6.
ACE Entry Filing Requirements for FDA-Regulated Goods Finalised
The Food and Drug Administration has issued a final rule that, effective 29 December, will require certain data elements material to admissibility reviews on imported FDA-regulated products to be submitted in the Automated Commercial Environment (or any other electronic data interchange system authorized by U.S. Customs and Border Protection) at the time of entry.
Economists' Pick 16 Dec 2016
7.
Imports of Synthetic Opioid Restricted
The Drug Enforcement Administration has issued a final order that temporarily schedules the synthetic opioid 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (also known as U-47700) and its isomers, esters, ethers, salts, and salts of isomers, esters and ethers into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act.
Economists' Pick 2 Dec 2016
8.
Argentina Bans Imports of Pure gamma-Butyrolactone and Ethyl Chloride, Amends Trade Controls on Drug Precursors
Argentina has banned through Disposition 11276/2016 the importation, exportation and sale of pure gamma-butyrolactone (GBL) and ethyl chloride because these substances may be used as precursors in the manufacture of prohibited drugs.
Economists' Pick 4 Nov 2016
9.
FDA Warns Against Use of Homeopathic Teething Tablets and Gels
The Food and Drug Administration is warning U.S. consumers against the use of homeopathic teething tablets and gels because they may pose a health risk to infants and children.
Economists' Pick 4 Nov 2016
10.
Import Controls Imposed on Three Synthetic Phenethylamines
The DEA has issued a final rule that, effective 27 October, will permanently place the following substances, including their optical, positional, and geometric isomers, salts, and salts of isomers whenever their existence is possible, into schedule I of the Controlled Substances Act.
Economists' Pick 7 Oct 2016
11.
Moves to Fuse TCM with Western Medicine Gaining Traction Across Asia
With the active ingredients in Traditional Chinese Medicine now far better understood than ever before, a new range of hybrid TCM/Western treatments are wooing even the most cynical with their efficacy and lack of side-effects.
Economists' Pick 28 Sept 2016
12.
FDA Revises Regulations on Foreign and Domestic Drug Establishment Registration
The FDA has issued a final rule that reorganises, modifies and clarifies its regulations concerning how and when owners or operators of foreign and domestic establishments at which drugs are manufactured or processed must register their establishments with the FDA and list the drugs they manufacture or process.
Economists' Pick 23 Sept 2016
13.
Asia Poised to Step Up as World's Second Largest Medtech Market
Thanks to the ever-rising wealth and increased longevity of its citizens, Asia will soon be second only to the US as a medtech market, with diagnostically-enabled wearables and the digitisation of medicine set to make a huge impact.
Economists' Pick 23 Sept 2016
14.
Mexican Health Ministry Issues Updated Guidelines to Validate GMP Certificates for Drugs
Mexico’s Ministry of Health recently issued an updated set of guidelines that officials must follow to validate good manufacturing practices certificates for drugs and medicaments.
Economists' Pick 9 Sept 2016
15.
Dates for Healthcare Business Development Mission to Mainland China Modified
The ITA has announced that its executive-led healthcare business development mission to mainland China will take place on 16-21 October rather than on 23-28 October as originally planned.
Economists' Pick 9 Sept 2016
16.
Labelling Regulations for Veterinary Biological Products Amended
The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service has amended effective 31 October the Virus-Serum-Toxin Act regulations regarding the packaging and labelling of veterinary biological products.
Economists' Pick 9 Sept 2016
17.
VIETNAM: Healthcare FDI Approved as Conditional Investment List Continues to Dwindle
A number of healthcare sectors in Vietnam will now be opened up for overseas financing for the first time following a proposal to remove them from the prescribed products and services detailed on the government’s conditional investment list.
Economists' Pick 8 Sept 2016
18.
Creating Synergies at the Hong Kong International Medical Devices and Supplies Fair Multimedia
Wissner-Bossnerhoff, a German company, showcased their latest innovations for the institutionalized care market at the Hong Kong International Medical Devices and Supplies Fair. In this podcast interview, Christopher Loy, Area Sales Manager Asia/Australia, Wissner-Bossnerhoff, highlights the importance of partnership in the Asian market and explains how attending the fair in Hong Kong allows them to share their expertise and leverage market synergies to expand their venture.
Multimedia 15 Aug 2016
19.
New Market Opportunities for Defibrillators in Hong Kong Multimedia
While attending the Hong Kong International Medical Devices and Supplies Fair, Julian Cosgrave, General Manager, APL Healthcare Asia, explained that Hong Kong’s role as an international city presents great opportunities for his company to expand into China and other Asian markets. As well, he has high hopes for his company’s line of defibrillator products in the Hong Kong market as he believes that greater public awareness and accessibility of this technology can help save lives in the city.
Multimedia 9 Aug 2016
20.
Major Cities Turn to Suburbs and Nearby Provinces for Elderly Care
With the aging population of tier one cities requiring a huge surge in the number of residential care facilities, the lower land costs in suburban areas and neighbouring provinces are seen as providing a cost-effective solution for this growing problem.
Economists' Pick 1 Aug 2016
Items Per Page
Page  Of   8
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 Next